Latest
Bill Analysis
|
January 28, 2026
Analysis of Title VII: Lowering Prescription Drug Costs & Other Related Provisions
The Great Health Care Plan, introduced by the Trump Administration, fundamentally supports 1) giving Americans their health dollars, 2) giving Americans transparency into costs, and 3) giving Americans more options for how to pay for their healthcare. Title VII in H.R. 7148 and other related healthcare provisions in this bill that passed the House on January 22, 2026, achieve many of the goals outlined in President Trump’s plan.
Commentary
|
January 28, 2026
Which Pharmacy Do I Send it To? Commonsense Reforms to Lower Prices
Price transparency is foundational to lower health care costs for all Americans. When patients can compare the price of a service at multiple facilities, they can choose the provider that offers the best value at lowest cost. Drug costs are no different.
Fact Sheet
|
January 28, 2026
Promises Kept: Protecting American Children from Chemical and Surgical
The Trump Administration has set out to purge gender ideology from the federal government and dismantle the social institutions that indoctrinate children as well as to ban the practice of child chemical and surgical mutilation and impose sufficient pressure on the medical community to abandon it as a discipline. Given the irreversible consequences of these procedures, it’s not surprising that President Trump’s policies command robust support—polls show that 56% of Americans favor banning interventions like puberty blockers, hormone therapies and surgeries on children.[1]
Statement
|
January 23, 2026
AFPI Celebrates the End of Human Fetal Tissue in Taxpayer-Funded Research
AFPI applauds the NIH for ending the use of human fetal tissue in taxpayer funded, NIH supported research. Instead, the Trump Administration is advancing innovative technologies to conduct more effective bio medical testing without the cost to unborn life. This decision marks a turning point for gold-standard science in the United States.
Statement
|
January 22, 2026
Putting Patients First: New Reforms Give Patients Their Money, Their Prices, and More Options
Washington, D.C.—Today, Hannah Anderson, Director of Healthy America Policy and Senior Director of Policy at the America First Policy Institute (AFPI), issued the following statement in response to congressional passage of a government funding package that includes pharmacy benefit manager (PBM) reforms: “This legislation takes an important step towards putting patients—not middlemen—in charge of their healthcare dollars and decisions. For too long, patients have been forced to navigate a system where costs are hidden, competition is distorted, and intermediaries profit. Meanwhile, as PBMs operate in the shadows, the patient has no idea how much of a cut middlemen are receiving from their medication, or that another nearby pharmacy may offer a lower-cost option.
Experts on Healthcare Reform
Videos
Selected...
Which Pharmacy Do I Send it To? Commonsense Reforms to Lower Prices
Selected...
Defining Issues and Strategies: America First in 2026
Selected...
Putting Patients First: Hannah Anderson & Dr. Tom Keane on Health Tech
Selected...
No More Surprise Bills: Hannah Anderson and Mark Atalla on Drug Price Transparency
Selected...
Make America Healthy Again by Reducing the cost of Health Care
Selected...
America First Unfiltered: Major Wins from President Trump’s White House – Feb. 28, 2025
Selected...
The Results Are In: Obamacare Has Failed
Selected...
Combating Fentanyl in Schools
Selected...
Key Points of the Hospital Price Transparency Act
Selected...
Hospital Price Transparency Act
Selected...